- Home
- PUMP vs RVNC Comparison
PUMP vs RVNC Comparison
Compare PUMP & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUMP
- RVNC
- Stock Information
- Founded
- PUMP 2007
- RVNC 1999
- Country
- PUMP United States
- RVNC United States
- Employees
- PUMP N/A
- RVNC N/A
- Industry
- PUMP Oilfield Services/Equipment
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- PUMP Energy
- RVNC Health Care
- Exchange
- PUMP Nasdaq
- RVNC Nasdaq
- Market Cap
- PUMP 719.0M
- RVNC 599.6M
- IPO Year
- PUMP 2017
- RVNC 2014
- Fundamental
- Price
- PUMP $7.57
- RVNC $4.17
- Analyst Decision
- PUMP Buy
- RVNC Buy
- Analyst Count
- PUMP 6
- RVNC 10
- Target Price
- PUMP $11.00
- RVNC $10.23
- AVG Volume (30 Days)
- PUMP 1.3M
- RVNC 2.8M
- Earning Date
- PUMP 10-30-2024
- RVNC 11-07-2024
- Dividend Yield
- PUMP N/A
- RVNC N/A
- EPS Growth
- PUMP N/A
- RVNC N/A
- EPS
- PUMP N/A
- RVNC N/A
- Revenue
- PUMP $1,471,508,000.00
- RVNC $256,945,000.00
- Revenue This Year
- PUMP N/A
- RVNC $20.36
- Revenue Next Year
- PUMP N/A
- RVNC $31.66
- P/E Ratio
- PUMP N/A
- RVNC N/A
- Revenue Growth
- PUMP N/A
- RVNC 25.82
- 52 Week Low
- PUMP $6.54
- RVNC $2.30
- 52 Week High
- PUMP $10.02
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- PUMP 47.42
- RVNC 36.84
- Support Level
- PUMP $7.59
- RVNC $3.36
- Resistance Level
- PUMP $8.25
- RVNC $4.37
- Average True Range (ATR)
- PUMP 0.42
- RVNC 0.31
- MACD
- PUMP 0.04
- RVNC -0.15
- Stochastic Oscillator
- PUMP 53.21
- RVNC 31.03
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and coiled tubing.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.